Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 49 | 51 | 58 | 83 | 2 |
| Income taxes - deferred | 70 | 104 | 17 | 30 | N/A |
| Accounts receivable | 17 | 65 | -155 | 20 | -127 |
| Accounts payable and accrued liabilities | N/A | N/A | -620 | 916 | 277 |
| Other Working Capital | -40 | -130 | -969 | 1,240 | 21 |
| Other Operating Activity | -4,832 | -4,948 | -4,632 | -6,025 | -2,461 |
| Operating Cash Flow | $-4,734 | $-4,859 | $-6,301 | $-3,735 | $-2,288 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 0 | -6 | -27 |
| Purchase Of Investment | -715 | -350 | N/A | N/A | N/A |
| Sale Of Investment | 186 | 79 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | 0 | 0 | -160 |
| Other Investing Activity | -13 | 34 | -26 | 0 | -16 |
| Investing Cash Flow | $-542 | $-238 | $-26 | $-6 | $-203 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,250 | N/A | N/A | N/A | N/A |
| Debt Repayment | -43 | -43 | -41 | -57 | N/A |
| Common Stock Issued | 0 | 2,192 | 11,115 | 584 | 6,233 |
| Other Financing Activity | 415 | 4,105 | 590 | -14 | -298 |
| Financing Cash Flow | $2,623 | $6,254 | $11,664 | $513 | $5,936 |
| Exchange Rate Effect | 3 | -12 | -38 | -23 | N/A |
| Beginning Cash Position | 6,574 | 5,428 | 129 | 3,380 | 266 |
| End Cash Position | 3,923 | 6,574 | 5,428 | 129 | 3,727 |
| Net Cash Flow | $-2,654 | $1,158 | $5,337 | $-3,228 | $3,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,734 | -4,859 | -6,301 | -3,735 | -2,288 |
| Capital Expenditure | N/A | N/A | N/A | -6 | -187 |
| Free Cash Flow | -4,734 | -4,859 | -6,301 | -3,741 | -2,474 |